A track record
you can verify.
A proven record across the PhaseWell network, from studies completed and approvals supported to a clean regulatory history sponsors can rely on.
Proof, not promises.
See how the PhaseWell network turns local reach and operational discipline into measurable results for sponsors, from accelerated enrollment to the quality standards that keep studies on track.
CNS
#1 enrolling site in a Phase II Alzheimer's trial
A high-volume recruitment strategy doubled enrollment goals to lead 39 U.S. sites.
Cardiometabolic
One site, more than a quarter of Puerto Rico's MASH enrollment
Onsite FibroScan cut MASH screen fails to deliver 27% of regional enrollment.
CNS
#1 enrolling site worldwide in a psychedelic TRD trial
A sharp prescreen met tough TRD criteria, achieving #1 enrollment and 96% retention.
Oncology
From first meeting to greenlight in 43 days
A sprint start-up gave a lagging myeloma study a greenlit U.S. site in 43 days.
CNS
Recruiting the right patients for a landmark schizophrenia approval
Community referrals met tight schizophrenia criteria, supporting FDA approval.